UNIKUM Therapeutics ApS: Financial statements 2025
CVR: 41192925
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
UNIKUM Therapeutics ApS (CVR 41192925) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.
- Gross Profit
- DKK -247,887
- Profit/Loss
- DKK -859,076
- Equity
- DKK -5,680,033
- Total Assets
- DKK 137,899
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -248K | -859K | -5.7M | 0 |
| 2024 | - | -7.4M | -13.8M | -4.8M | 9 |
| 2023 | - | -7.5M | -14.9M | -16.3M | 9 |
| 2022 | - | -3.3M | -7.6M | -15.3M | 7 |
| 2021 | - | -2.7M | -5.6M | -7.6M | 5 |
Official annual report
How creditworthy is UNIKUM Therapeutics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
UNIKUM Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -7,368,177, and the net result was DKK -13,797,011.
As of May 27, 2025, Nebojsa Milovic has left the board of directors of UNIKUM Therapeutics ApS.
As of May 27, 2025, Margo Rosemary Roberts has left the board of directors of UNIKUM Therapeutics ApS.
About UNIKUM Therapeutics ApS
UNIKUM Therapeutics ApS is a Danish company of the type Anpartsselskab based in Risskov, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Roelsgaard Jakobsen. The board consists of Ulrik Bjerl Nielsen (chair), Martin Roelsgaard Jakobsen and Stefan Wildt. The company's owners include MEDIC ADVICE ApS, MR Jakobsen Holding ApS and BII Holdings A/S. The company has 2 employees (2025). In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.
